Suppliers / Jiangsu Tasly Diyi Pharmaceutical

Jiangsu Tasly Diyi Pharmaceutical

China 43 employees Updated 9 July 2026

Jiangsu Tasly Diyi Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Its filings concentrate with NMPA (CN), DAV (Vietnam) and NPRA (MY). Its GMP standing is certified by MFDS (Korea).

2
active US DMFs
0
valid CEPs
1
registered plants
22
filings across 3 regulators

Registered plants

Site FDA FEI
Huai'an City, China Not on file

What they file, and where

Molecule Regulators Docs
Pimavanserin US FDA 1
Temozolomide US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
NMPA (CN) 16 None
DAV (Vietnam) 4 None
NPRA (MY) 2 None
MFDS (Korea) None 2

Comparing suppliers?

Choose your molecules and target markets. Jiangsu Tasly Diyi Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates